@itraslan @DrToddLee the evidence for use of CDT is actually less than for thrombolytic therapy interestingly Cochrane thrombolytic: https://t.co/4n9EntyOLj Cochrane CDT: https://t.co/3PSBA9eAzF

RT @CochraneVasc: #CochraneEvidence on thrombolytics to treat #PE updated https://t.co/UOD2JScIO5 @PERTConsortium @VSGBI @isth @SCoRMember…

#CochraneEvidence on thrombolytics to treat #PE updated https://t.co/UOD2JScIO5 @PERTConsortium @VSGBI @isth @SCoRMembers #stoptheclot https://t.co/mDSLUJwYzU

RT @CochraneVasc: #CochraneEvidence on thrombolytics to treat #PE updated https://t.co/UOD2JScIO5 @PERTConsortium @VSGBI @isth @SCoRMember…

RT @CochraneVasc: #CochraneEvidence on thrombolytics to treat #PE updated https://t.co/UOD2JScIO5 @PERTConsortium @VSGBI @isth @SCoRMember…

#CochraneEvidence on thrombolytics to treat #PE updated https://t.co/UOD2JScIO5 @PERTConsortium @VSGBI @isth @SCoRMembers #stoptheclot https://t.co/8eeFzTyTeQ

#CochraneEvidence on thrombolytics to treat #PE updated https://t.co/UOD2JScIO5 @PERTConsortium @isth @SCoRMembers #stoptheclot @VSGBI https://t.co/VkmpL0GMit

RT @Links_Medicus: Systematic review: Thrombolytic therapy for acute massive or submassive pulmonary embolism – via @CochraneLibrary https…

RT @Links_Medicus: Systematic review: Thrombolytic therapy for acute massive or submassive pulmonary embolism – via @CochraneLibrary https…

RT @Links_Medicus: Systematic review: Thrombolytic therapy for acute massive or submassive pulmonary embolism – via @CochraneLibrary https…

Systematic review: Thrombolytic therapy for acute massive or submassive pulmonary embolism – via @CochraneLibrary https://t.co/6X31PBm4H3 Summary: https://t.co/NQ5qaEuB8C

@CochraneVasc update: low‐quality evidence suggests that thrombolytic therapy reduces death following acute #PE vs heparin, may reduce recurrence of PE but may cause major & minor haemorrhagic events & stroke. https://t.co/FWtfG6QJvC

RT @PontealdiaURG: T1E2A1 En #emboliapulmonar 🩸 grave o masiva la terapia trombolítica 💉 reduce la mortalidad aunque con evidencia baja.…

RT @CochraneUK: Low‐quality evidence suggests that thrombolytic therapy reduces death following acute pulmonary embolism (PE) vs heparin, m…

T1E2A1 En #emboliapulmonar 🩸 grave o masiva la terapia trombolítica 💉 reduce la mortalidad aunque con evidencia baja. 🧪Se necesitan más ensayos de alta calidad. Vía @CochraneUK https://t.co/7VvVSC2bWq

RT @CochraneUK: Low‐quality evidence suggests that thrombolytic therapy reduces death following acute pulmonary embolism (PE) vs heparin, m…

In other words 🤷🏼‍♀️

Low‐quality evidence suggests that thrombolytic therapy reduces death following acute pulmonary embolism (PE) vs heparin, may reduce recurrence of PE but may cause major & minor haemorrhagic events & stroke. https://t.co/QCb9wsbxhN Update from @Coc

RT @cochrane_nz: #CochraneEvidence update: low‐quality evidence suggests that thrombolytic therapy reduces death following acute #PE vs hep…

#CochraneEvidence update: low‐quality evidence suggests that thrombolytic therapy reduces death following acute #PE vs heparin, may reduce recurrence of PE but may cause major & minor haemorrhagic events & stroke https://t.co/s2xH2Klc8w @TheRACP

Maybe this study from @cochranecollab might hold a clue to treating the blood clotting complications found in covid-19 patients - link: https://t.co/9J7DyoqXwv. A mysterious blood-clotting complication is killing coronavirus patients https://t.co/Bgv12vaS

Thrombolytic therapy for pulmonary embolism. https://t.co/rAJCZrgvCW

RT @CochraneVasc: #CochraneEvidence update: low‐quality evidence suggests that thrombolytic therapy reduces death following acute #PE vs he…

RT @CochraneVasc: #CochraneEvidence update: low‐quality evidence suggests that thrombolytic therapy reduces death following acute #PE vs he…

#CochraneEvidence update: low‐quality evidence suggests that thrombolytic therapy reduces death following acute #PE vs heparin, may reduce recurrence of PE but may cause major & minor haemorrhagic events & stroke https://t.co/xf5cSEdUze @isth @V